Kinliv

Kinliv is a specialized pharmaceutical injectable formulation that consists of L-Ornithine L Aspartate 5gm. It is supplied in a 10 mL ampoule with tray. L-Ornithine L-Aspartate is a combination of the amino acids ornithine and aspartate and is used in clinical practice in situations where a medical professional finds it right. Kinliv should be used only upon a healthcare professional’s advice. The dosage and route of administration along with treatment duration and suitability rely on the patient’s medical condition and the prescribing physician’s verification.

Composition of Kinliv

The active ingredient of Kinliv is:

L-Ornithine L-Aspartate – 5 gm

Key Features of Kinliv

Kinliv provides an easy injectable presentation for professional healthcare situations. Its major product details consists of:

• Brand name:Kinliv
• Composition:L-Ornithine L-Aspartate 5 gm
• Dosage form:Injectable formulation
• Pack:10 mL ampoule with tray
• Division:Hopkins Intensive Care
• Product range:Liquid Injectable Range

The injectable format allows the product to be administered by trained healthcare professionals when clinically indicated.

Clinical Use and Administration

L-Ornithine L-Aspartate is used under medical supervision for appropriate clinical indications determined by a physician. Because Kinliv is an injectable pharmaceutical product, it should not be self-administered or used without professional guidance.

The prescribing healthcare professional determines the appropriate dosage and administration based on factors such as the patient’s condition, medical history, concurrent medicines, and overall clinical requirements. Patients should follow the prescribed instructions carefully and should not alter the recommended dose or duration of treatment without consulting their healthcare provider.

Quality-Focused Pharmaceutical Product

Diya Healthcare states that it focuses on quality, regulatory compliance, ethical practices, and reliable pharmaceutical supply. The company describes its manufacturing and quality-control processes as being designed to meet stringent standards, with GMP-compliant manufacturing and strict quality-control practices.

These quality considerations are particularly relevant for injectable medicines, where appropriate manufacturing, testing, packaging, storage, and handling are essential to maintaining product quality.

Packaging and Availability

Kinliv is listed in a 10 mL ampoule with tray presentation.

The product is part of Diya Healthcare’s broader injectable portfolio and can be considered by healthcare professionals, pharmaceutical distributors, and authorized business partners seeking specialized injectable formulations.

For commercial enquiries, product availability, or distribution information, customers can contact Diya Healthcare through its official communication channels. The company lists its office in Chandigarh and provides dedicated contact details for healthcare and business enquiries

Conclusion

Kinliv (L-Ornithine L-Aspartate 5 gm) is a specialized injectable pharmaceutical formulation from Diya Healthcare’s Hopkins Intensive Care range. Supplied as a 10 mL ampoule with tray, it provides a professional injectable presentation of L-Ornithine L-Aspartate for use when considered appropriate by a qualified healthcare professional.